Trial of hydrazine sulfate (NSC-150014) in patients with cancer.
D001772:Blood Cell Count; D001786:Blood Glucose / Q000378:metabolism; D002986:Clinical Trials as Topic; D004576:Electromyography; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D009461:Neurologic Manifestations
D001786:Blood Glucose; D006834:Hydrazines